title: Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis.
authors.forename: V
authors.initials: V
authors.lastname: Di Marco
authors.forename: S
authors.initials: S
authors.lastname: De Lisi
authors.forename: M
authors.initials: M
authors.lastname: Li Vecchi
authors.forename: S
authors.initials: S
authors.lastname: Maringhini
authors.forename: F
authors.initials: F
authors.lastname: Barbaria
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000150:complications* / Q000209:etiology / Q000276:immunology; D005938:Glucocorticoids / Q000627:therapeutic use*; D006509:Hepatitis B / Q000188:drug therapy*; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007678:Kidney Glomerulus / Q000276:immunology; D007687:Kidney Tubules, Proximal / Q000276:immunology; D019259:Lamivudine / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D005938:Glucocorticoids; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D011241:Prednisone; D008775:Methylprednisolone